Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
Q2 2023 vs. Q1 2023
How the institutions holding Genmab A/S changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 217 | 214 | −3 |
| Shares | 43.6M | 41.7M | −1.88M (−4.3%) |
| Value | $1.62B | $1.59B | −$35.9M (−2.2%) |
New holders (29)
Institutions that held Genmab A/S at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (32)
Institutions that held Genmab A/S at the end of Q1 2023 and filed for Q2 2023 without it.